Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer

Journal of Surgical Oncology

Volumn 100, Issue 6, 2009, Pages 442-446

  Miyata, Hiroshi ^a   Yamasaki, Makoto ^a   Takiguchi, Shuji ^a   Nakajima, Kiyokazu ^a   Fujiwara, Yoshiyuki ^a   Nishida, Toshiro ^a   Mori, Masaki ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiotherapy; Esophageal cancer; Prognosis; Salvage surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOVASCULAR DISEASE; CONTINUOUS INFUSION; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; INFECTION; LUNG DISEASE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT LARYNGEAL NERVE PALSY; REOPERATION; SALVAGE THERAPY; SURGICAL APPROACH; SURGICAL MORTALITY; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 70350336280     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21353     Document Type: Article

References (45)

1. Earlam R, Cunha-Melo JR: Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980;67:381-390.
2. Muller JM, Erasmi H, Stelzner M, et al.: Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-857.
3. Skinner D: Surgical treatment for esophageal carcinoma. Semin Oncol 1984;11:136-143.
4. Roder JD, Busch R, Stein HJ, et al.: Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994;81:410-413. (Pubitemid 24124822)
5. Kelsen DP, Ginsberg R, Pajak TF, et al.: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-1984. (Pubitemid 29024130)
6. Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomized controlled trial. Lancet 2002;359:1727-1733.
7. Ando N, Iizuka T, Kakegawa T, et al.: A randomized trial of surgery with and without chemotherapy for localized squamous cell carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 1997;114:205-209. (Pubitemid 27364210)
8. Arnott SJ, Duncan W, Kerr GR, et al.: Low-dose preoperative radiotherapy for carcinoma of the oesophagus: Results of a randomized clinical trial. Radiother Oncol 1992;24:108-113.
9. Bernard EL, Inculet RI, Malthaner RA, et al.: The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 2001;91:2423-2430.
10. Walsh TN, Noonan N, Hollywood D, et al.: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467. (Pubitemid 26269945)
11. Bosset JF, Gignoux M, Triboulet JP, et al.: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167. (Pubitemid 27306287)
12. Urba S, Orringer M, Turrisi A, et al.: A randomized trial comparing surgery (S) to preoperative concomitant chemoradiation plus surgery in patients (pts) with respectable esophageal cancer (CA): Updated analysis. Proc Am Soc Clin Oncol 1997;16:A983.
13. Nyggard K, Hagen S, Hansen HS, et al.: Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-1110. (Pubitemid 23065529)
14. Le Prise E, Etienne PL, Meunier B, et al.: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-1784. (Pubitemid 24101950)
15. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41:391-393. (Pubitemid 24273251)
16. Burmeister BH, Smithers BM, Gebski V, et al.: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 2005;6:659-668. (Pubitemid 41222756)
17. Tepper J, Krasna MJ, Niedzwiecki D, et al.: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008;26:1086-1092.
18. Gebski V, Burmeister B, Smithers BM, et al.: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 2007;8:226-234. (Pubitemid 46291702)
19. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for respectable esophageal cancer. Am J Surg 2003;185:538-543.
20. Chan A, Wong A: Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiat Oncol Biol Phys 1999;45:265-270.
21. Murakami M, Kuroda Y, Nakajima T, et al.: Comparison between chemoradiation protocol intended organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 1999;45:277-284. (Pubitemid 29408539)
22. Herskovic A, Martz K, al-Sarraf M, et al.: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.
23. al-Sarraf M, Martz K, Herskovic A, et al.: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997;15:277-284.
24. Smith TJ, Ryan LM, Douglass HO, Jr., et al.: Combined chemoradiotherapy vs radiotherapy alone for early stage squamous cell carcinoma of the esophagus. Int J Radiat Oncol Phys 1998;42:269-276.
25. Cooper JS, Guo MD, Herskovic A, et al.: Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. J Am Med Assoc 1999;281:623-627. (Pubitemid 29211772)
26. Kavanagh B, Anscher M, Leopold K, et al.: Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys 1992;24:633-642.
27. Roca E, Pennella E, Sardi M, et al.: Combined intensive chemoradiotherapy for organ preservation in patients with respectable and non-resectable oesophageal cancer. Eur J Cancer 1996;32A:429-432. (Pubitemid 26101832)
28. Minsky BD, Pajak TF, Ginsberg RJ, et al.: INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard dose radiation therapy. J Clin Oncol 2002;20:1167-1174.
29. Swisher SG, Wynn P, Putnam JB, et al.: Savage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 2002;123:175-183.
30. Gardner-Thorpe J, Hardwick RH, Dwerryhouse SJ: Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg 2007;94:1059-1066. (Pubitemid 350082848)
31. Meunier B, Raoul J, Le Prise E, et al.: Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus. Dig Surg 1998;15:224-226. (Pubitemid 28223151)
32. Wilson KS, Wilson AG, Dewar GJ: Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998. Can J Gastroenterol 1998;16:361-368.
33. Tomimaru Y, Yano M, Takachi K, et al.: Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol 2006;93:422-428.
34. Nakamura T, Hayashi K, Ota M, et al.: Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004;188:261-266. (Pubitemid 39278283)
35. Yano M, Yasuda T, Miyata H, et al.: Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus. J Surg Oncol 2005;89:244-250. (Pubitemid 40333532)
36. Tachimori Y, Kanamori N, Uemura N, et al.: Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2009;137:49-54.
37. Smithers BM, Cullinan M, Thomas JM, et al.: Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy. Dis Esophagus 2007;20:471-477. (Pubitemid 47617830)
38. Geh JI, Crellin AM, Glynne-Jones R: Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88:338-356. (Pubitemid 32238694)
39. Adelstein DJ, Rice TW, Becker M, et al.: Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997;80:1011-1120. (Pubitemid 27427599)
40. Stahl M, Wilke H, Fink U, et al.: Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. J Clin Oncol 1996;14:829-837.
41. Chidel MA, Rice TW, Adelstein DJ, et al.: Resectable esophageal carcinoma: Local control with neoadjuvant chemotherapy and radiation therapy. Radiology 1999;213:67-72. (Pubitemid 29470407)
42. Keller SM, Ryan LM, Coia LR, et al.: High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction. Cancer 1998;83:1908-1916.
43. Heidecke CD, Weighardt H, Feith M, et al.: Neoadjuvant treatment of esophageal cancer: Immunosuppression following radiochemotherapy. Surgery 2002;132:495-501. (Pubitemid 35155484)
44. Peyre CG, Hagen JA, DeMeester SR, et al.: Predicting systemic disease in patients with esophageal cancer after esophagectomy: A multinational study on the significance of the number of involved lymph nodes. Ann Surg 2008;248:979-985.
45. Gu Y, Swisher SG, Ajani JA, et al.: The number of lymph nodes with metastasis predicts survival in patients with esophageal or esphagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 2006;106:1017-1025. (Pubitemid 43297339)